` Comparison: ONCT vs AMGN - Alpha Spread

ONCT
vs
AMGN

Over the past 12 months, ONCT has underperformed AMGN, delivering a return of 0% compared to the AMGN's +25% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ONCT
AMGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ONCT Intrinsic Value
1.7561 USD
Undervaluation 70%
Intrinsic Value
Price
AMGN Intrinsic Value
329.18 USD
Overvaluation 10%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Oncternal Therapeutics Inc
NASDAQ:ONCT
0.5266 USD
Amgen Inc
NASDAQ:AMGN
365.13 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ONCT, AMGN

ONCT
AMGN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Oncternal Therapeutics Inc
Revenue
Amgen Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ONCT, AMGN

ONCT
AMGN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Oncternal Therapeutics Inc
NASDAQ:ONCT
Amgen Inc
NASDAQ:AMGN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ONCT
0%
AMGN
82.5%

Operating Margin

ONCT
-1 664%
AMGN
44.1%

Net Margin

ONCT
-1 600%
AMGN
21%

FCF Margin

ONCT
-1 232.4%
AMGN
22%

ROE

ONCT
-149.9%
AMGN
106.1%

ROA

ONCT
-117.6%
AMGN
8.5%

ROIC

ONCT
-12 357%
AMGN
20.1%

ROCE

ONCT
-152.4%
AMGN
24.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ONCT, AMGN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ONCT, AMGN

Loading
ONCT
AMGN
Difference
www.alphaspread.com

Performance By Year
ONCT, AMGN

Loading
ONCT
AMGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ONCT to other stocks
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
GILD
Gilead Sciences Inc
VRTX
Vertex Pharmaceuticals I...
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account